22. Perioperative Kardioprotektion

Zurück zum Zitat Armitage J, Bowan L, Collins R, Parish S, Tobert T for the Heart Protection Study Collaborators (2009) Effect of simvastatin 40 mg daily on muscle and liver adverse effects in a 5 year randomized placebo controlled study in 20536 high risk people. BMCCIinPhamacoI9:6 Armitage J, Bowan L, Collins R, Parish S, Tobert T for the Heart Protection Study Collaborators (2009) Effect of simvastatin 40 mg daily on muscle and liver adverse effects in a 5 year randomized placebo controlled study in 20536 high risk people. BMCCIinPhamacoI9:6

Zurück zum Zitat Brady AR, Gibbs JS, Greenhalgh RM et al. (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vase Surg 41:602–609CrossRef Brady AR, Gibbs JS, Greenhalgh RM et al. (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vase Surg 41:602–609CrossRef

Zurück zum Zitat De Hert SG, Van der Linden PJ, Cromheecke S et al. (2004) Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101:299–310PubMedCrossRef De Hert SG, Van der Linden PJ, Cromheecke S et al. (2004) Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101:299–310PubMedCrossRef

Zurück zum Zitat Devereaux PJ, Yang H, Yusuf S et al. (2008) Effects of extendedrelease metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847PubMedCrossRef Devereaux PJ, Yang H, Yusuf S et al. (2008) Effects of extendedrelease metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847PubMedCrossRef

Zurück zum Zitat Durazzo AE, Machado FS, Ikeoka DT et al. (2004) Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vase Surg 39:967–975CrossRef Durazzo AE, Machado FS, Ikeoka DT et al. (2004) Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vase Surg 39:967–975CrossRef

Zurück zum Zitat Fleisher LA, Beckman JA, Brown KA et al. (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116: e418–499PubMedCrossRef Fleisher LA, Beckman JA, Brown KA et al. (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116: e418–499PubMedCrossRef

Zurück zum Zitat Hindler K, Shaw AD, Samuels J et al. (2006) Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105:1260–1272PubMedCrossRef Hindler K, Shaw AD, Samuels J et al. (2006) Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105:1260–1272PubMedCrossRef

Zurück zum Zitat Juul AB, Wetterslev J, Kofoed-Enevoldsen A et al. (2004) The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 147:677–683PubMedCrossRef Juul AB, Wetterslev J, Kofoed-Enevoldsen A et al. (2004) The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 147:677–683PubMedCrossRef

Zurück zum Zitat Lee TH, Marcantonio ER, Mangione CM et al. (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100: 1043–1049PubMedCrossRef Lee TH, Marcantonio ER, Mangione CM et al. (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100: 1043–1049PubMedCrossRef

Zurück zum Zitat Lindenauer PK, Pekow P, Wang K et al. (2004) Lipid-Iowering therapy and in-hospital mortality following major noncardiac surgery. Jama 291:2092–2099PubMedCrossRef Lindenauer PK, Pekow P, Wang K et al. (2004) Lipid-Iowering therapy and in-hospital mortality following major noncardiac surgery. Jama 291:2092–2099PubMedCrossRef

Zurück zum Zitat Mangano DT, Layug EL, Wallace A,Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N EngI J Med 335:1713–1720CrossRef Mangano DT, Layug EL, Wallace A,Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N EngI J Med 335:1713–1720CrossRef

Zurück zum Zitat Poldermans D, Bax JJ, Boersma E et al. (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J (in press) Poldermans D, Bax JJ, Boersma E et al. (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J (in press)

Zurück zum Zitat Poldermans D, Boersma E, Bax JJ et al. (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N EngI J Med 341:1789–1794CrossRef Poldermans D, Boersma E, Bax JJ et al. (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N EngI J Med 341:1789–1794CrossRef

Zurück zum Zitat Smith SC, Jr., Allen J, Blair SN et al. (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113: 2363–2372PubMedCrossRef Smith SC, Jr., Allen J, Blair SN et al. (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113: 2363–2372PubMedCrossRef

Zurück zum Zitat Tonner PH, Scholz J (1996) Clinical perspectives of alpha2-adrenoceptor agonists. Current Opinion in Anaesthesiology 9: 471–480 Tonner PH, Scholz J (1996) Clinical perspectives of alpha2-adrenoceptor agonists. Current Opinion in Anaesthesiology 9: 471–480